Public-private partnership funding to support projects that translate health research and innovation into real benefits for patients and society, and pave the way for a more integrated approach to health care, covering prevention, diagnosis, treatment and disease management.
IHI’s general objectives are to:
- Turn health research and innovation into real benefits for patients and society.
- Deliver safe, effective health innovations that cover the entire spectrum of care – from prevention to diagnosis and treatment – particularly in areas where there is an unmet public health need.
- Make Europe’s health industries globally competitive.
This call consists of the following topics:
- A city-based approach to reducing cardiovascular mortality in Europe.
- Novel endpoints for osteoarthritis (OA) by applying big data analytics.
- Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation.
- Patient-centred clinical-study endpoints derived using digital health technologies.
Full details of each topic can be found in the call text below.
Other resources include general guidance for applicants, proposal templates and FAQs – all of which can be found on the IHI call documents page.
Presentations and recordings of information sessions are also available, along with a dedicated platform for finding potential partners (minimum consortium requirements apply – see FAQs).
Note that applicant consortia must ensure that at least 45% of eligible costs are provided by contributions from industry members (‘private partners’), their constituent or affiliated entities, and/or contributing partners. IHI industry members are as follows:
- COCIR
- EFPIA (including Vaccines Europe)
- EuropaBio
- MedTech Europe
First-stage application deadline: 10 October 2024
Full proposal deadline: 23 April 2025